Treatment of Mechanical Corneal Wounds Emergencies during the COVID-19 Pandemic: Absorbable 10-0 Vicryl (Polyglactin 910) Sutures as a Suitable Strategy.
COVID-19 pandemic
absorbable 10-0 Vicryl
absorbable 10-0 polyglactin 910
corneal wound
non-absorbable 10-0 Nylon
non-penetrating corneal laceration
personalized strategy
teleconsultation
Journal
Journal of personalized medicine
ISSN: 2075-4426
Titre abrégé: J Pers Med
Pays: Switzerland
ID NLM: 101602269
Informations de publication
Date de publication:
25 May 2022
25 May 2022
Historique:
received:
19
03
2022
revised:
16
05
2022
accepted:
23
05
2022
entrez:
24
6
2022
pubmed:
25
6
2022
medline:
25
6
2022
Statut:
epublish
Résumé
Background—The COVID-19 pandemic has changed our standard practices: operating rooms were only available for functional emergencies and outpatient visits were drastically reduced in favor of telemedicine. Aim: To report the personalized “one-shot” surgery using absorbable 10-0 Vicryl (V10-0) or polyglactin 910 monofilament in mechanical corneal injuries from February 2020 to December 2021. Methods—Prospective case series with at least 12-months’ follow-up, in a French university hospital. Among the overall population of open or closed-globe emergencies (n = 40), non-penetrating corneal lamellar lacerations (long axis > 2 mm) in zone 1 (OTC group) were treated with V10-0 suture(s) (n = 10), replacing traditional non-absorbable 10-0 nylon suture(s) or medical options in first line. The outpatient visits were performed on day (D)10, month (M)2, M6 then every six months. One interim visit by phone teleconsultation was scheduled between D10 and M2, and other(s) as needed. The main outcome was best-corrected visual acuity (BCVA) at M6. Secondary outcomes included mainly corneal astigmatism (CA) at M6 complications. Results—Among the ten corneal wounds, there were three children (30%), eight domestic accidents (80%), three eyes with metallic foreign bodies (30%), four open-globe injuries (40%), and nine eyes that received high-speed projectiles or sharp objects (90%). The complete V10-0 suture(s) absorption occurred in all eyes between D10 and M2. At M6, mean far and near BCVA decreased from 0.680 ± 0.753 and 0.490 ± 0.338 preoperatively to 0.050 ± 0.071 and 0.220 ± 0.063 logMAR (p = 0.019 and p = 0.025 respectively), mean CA decreased from 4.82 ± 3.86 preoperatively to 1.15 ± 0.66 diopters (p = 0.008). BCVA and CA were unchanged thereafter. No serious adverse event nor repeated surgery occurred. The mean number of teleconsultations was 1.20 ± 0.63 without an additional nonscheduled outpatient visit. Conclusions—The absorbable V10-0 sutures might be a safe and effective alternative for eligible corneal wounds, while reducing the number of outpatient visits, especially for children (no suture removal). The COVID-19 pandemic highlighted that they are ideally suited to logistical challenges.
Identifiants
pubmed: 35743651
pii: jpm12060866
doi: 10.3390/jpm12060866
pmc: PMC9225171
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
J Pediatr Ophthalmol Strabismus. 2010 Mar-Apr;47(2):88-95
pubmed: 20349901
Int Ophthalmol Clin. 2013 Fall;53(4):1-10
pubmed: 24088928
Value Health Reg Issues. 2022 Mar;28:46-53
pubmed: 34800831
Indian J Ophthalmol. 2018 May;66(5):661-664
pubmed: 29676310
Cornea. 2000 Sep;19(5):617-24
pubmed: 11009314
Hawaii Med J. 1997 Oct;56(10):292-4
pubmed: 9385749
Br J Ophthalmol. 1976 Jul;60(7):536-8
pubmed: 782510
Eye (Lond). 1994;8 ( Pt 3):343-5
pubmed: 7958044
Ophthalmic Epidemiol. 2006 Jun;13(3):209-16
pubmed: 16854775
Eye (Lond). 1998;12 ( Pt 3a):399-402
pubmed: 9775239
Aust N Z J Ophthalmol. 1992 May;20(2):95-8
pubmed: 1389141
J Natl Med Assoc. 1991 Aug;83(8):697-702
pubmed: 1956080
Ophthalmic Surg Lasers. 1999 Jul-Aug;30(7):554-9
pubmed: 10929979
Ophthalmol Clin North Am. 2002 Jun;15(2):139-43, v
pubmed: 12229228
Ophthalmol Clin North Am. 2002 Jun;15(2):163-5, vi
pubmed: 12229231
Arch Ophthalmol. 1983 Jun;101(6):919-24
pubmed: 6860205
Am J Ophthalmol. 2020 Aug;216:237-242
pubmed: 32360862
Indian J Ophthalmol. 2011 Nov-Dec;59(6):465-70
pubmed: 22011491
Semin Ophthalmol. 2020 May 18;35(4):210-215
pubmed: 32644878
Eye (Lond). 1999 Apr;13 ( Pt 2):215-20
pubmed: 10450385
Ophthalmic Epidemiol. 1998 Sep;5(3):143-69
pubmed: 9805347
Ophthalmology. 1990 May;97(5):581-4
pubmed: 2342802
Clin Ophthalmol. 2015 May 22;9:921-8
pubmed: 26045656
Rom J Ophthalmol. 2021 Jan-Mar;65(1):54-58
pubmed: 33817434
Ophthalmology. 1995 Jun;102(6):979-84
pubmed: 7777307
Am J Ophthalmol. 1997 Jun;123(6):820-31
pubmed: 9535627